Market spiral pricing of cancer drugs

E-ISSN： 1097-0142|119|22|3900-3902

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.22, 2013-11, pp. : 3900-3902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pricing and reimbursement of drugs in Ireland

By Barry Michael Tilson Lesley Ryan Máirín

The European Journal of Health Economics, Vol. 5, Iss. 2, 2004-05 ,pp. : 190-194

Springer Publishing Company

Access to resources Recommend Favorite

Orphan drugs: pricing, reimbursement and patient access

By Barak Adam Nandi Jyoti Shankar

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 4, 2011-11 ,pp. : 299-317

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Originator and generic medicine: pricing and market share

By Smit Eon van der Merwe Bredenkamp Jhandré

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 7, Iss. 2, 2013-06 ,pp. : 104-119

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Safety Screening of Drugs in Cancer Therapy

Acta Haematologica, Vol. 99, Iss. 3, 1998-04 ,pp. : 138-147

Karger

Access to resources Recommend Favorite

Skeletal Effects of Drugs to Treat Cancer

Current Drug Safety, Vol. 3, Iss. 3, 2008-09 ,pp. : 173-177

Bentham Science Publishers

Access to resources Recommend Favorite